Basic Information
RNALocate ID: | RLID:11003121 |
RNA Symbol: | hsa-miR-503-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-503-5p |
RNA ID: | miRBase:MIMAT0002874 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002358 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002359 | Mitochondrion | Myotube | 27396686 |
RLID:01002360 | Mitochondrion | Skeletal muscle cells | 27563705 |
RLID:01002361 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002362 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:11003117 | Exosome | Human umbilical vein endothelial cells | 25860935 |
RLID:11003118 | Exosome | Serum | 18589210 |
RLID:11003119 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11003120 | Exosome | Brain tissue | 23382797 |
RLID:11003122 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11003123 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000497 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001301 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-503-5p | Oral squamous cell carcinoma | MNDR-E-MI-55769 |
MNDR | hsa-miR-503-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-55770 |
MNDR | hsa-miR-503-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-55771 |
MNDR | hsa-miR-503-5p | Lymphoma | MNDR-E-MI-55772 |
MNDR | hsa-miR-503-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-55773 |
MNDR | hsa-miR-503-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-55774 |
MNDR | hsa-miR-503-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-55775 |
MNDR | hsa-miR-503-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-55776 |
MNDR | hsa-miR-503-5p | Breast cancer luminal | MNDR-E-MI-55777 |
MNDR | hsa-miR-503-5p | Dermatomyositis | MNDR-E-MI-55778 |
MNDR | hsa-miR-503-5p | Prostate cancer | MNDR-E-MI-55779 |
MNDR | hsa-miR-503-5p | Gastric cancer | MNDR-E-MI-55780 |
MNDR | hsa-miR-503-5p | Esophageal carcinoma | MNDR-E-MI-55781 |
MNDR | hsa-miR-503-5p | Dysautonomia familial | MNDR-E-MI-55782 |
MNDR | hsa-miR-503-5p | Seizures | MNDR-E-MI-55783 |
MNDR | hsa-miR-503-5p | Head and neck cancer | MNDR-E-MI-55784 |
MNDR | hsa-miR-503-5p | Leukemia | MNDR-E-MI-55785 |
MNDR | hsa-miR-503-5p | Cardiovascular disease | MNDR-E-MI-55786 |
MNDR | hsa-miR-503-5p | Lung cancer | MNDR-E-MI-55787 |
MNDR | hsa-miR-503-5p | Parkinson disease | MNDR-E-MI-55788 |
MNDR | hsa-miR-503-5p | Basal-like breast cancer | MNDR-E-MI-55789 |
MNDR | hsa-miR-503-5p | Neuroendocrine neoplasia | MNDR-E-MI-55790 |
MNDR | hsa-miR-503-5p | Squamous cell carcinoma | MNDR-E-MI-55791 |
MNDR | hsa-miR-503-5p | Pituitary neoplasms | MNDR-E-MI-55792 |
MNDR | hsa-miR-503-5p | Pancreatic cancer | MNDR-E-MI-55793 |
MNDR | hsa-miR-503-5p | Melanoma | MNDR-E-MI-55794 |
MNDR | hsa-miR-503-5p | Rectum adenocarcinoma | MNDR-E-MI-55795 |
MNDR | hsa-miR-503-5p | Nephroblastoma | MNDR-E-MI-55796 |
MNDR | hsa-miR-503-5p | Colon cancer | MNDR-E-MI-55797 |
MNDR | hsa-miR-503-5p | Colon adenocarcinoma | MNDR-E-MI-55798 |
MNDR | hsa-miR-503-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-55799 |
MNDR | hsa-miR-503-5p | Acromegaly | MNDR-E-MI-55800 |
MNDR | hsa-miR-503-5p | Prostate adenocarcinoma | MNDR-E-MI-55801 |
MNDR | hsa-miR-503-5p | Adenocarcinoma | MNDR-E-MI-55802 |
MNDR | hsa-miR-503-5p | Carcinoma ductal breast | MNDR-E-MI-55803 |
MNDR | hsa-miR-503-5p | Glioblastoma | MNDR-E-MI-55804 |
MNDR | hsa-miR-503-5p | Astrocytoma | MNDR-E-MI-55805 |
MNDR | hsa-miR-503-5p | Glioma | MNDR-E-MI-55806 |
MNDR | hsa-miR-503-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-55807 |
MNDR | hsa-miR-503-5p | Osteosarcoma | MNDR-E-MI-55808 |
MNDR | hsa-miR-503-5p | Breast carcinoma | MNDR-E-MI-55809 |
MNDR | hsa-miR-503-5p | Infarction middle cerebral artery | MNDR-E-MI-55810 |
MNDR | hsa-miR-503-5p | Gastric adenocarcinoma | MNDR-E-MI-55811 |
MNDR | hsa-miR-503-5p | Pituitary adenoma | MNDR-E-MI-55812 |
MNDR | hsa-miR-503-5p | Lung squamous cell carcinoma | MNDR-E-MI-55813 |
MNDR | hsa-miR-503-5p | Lung adenocarcinoma | MNDR-E-MI-55814 |
MNDR | hsa-miR-503-5p | Adrenocortical cancer | MNDR-E-MI-55815 |
MNDR | hsa-miR-503-5p | Thyroid carcinoma | MNDR-E-MI-55816 |
MNDR | hsa-miR-503-5p | Ovarian carcinoma | MNDR-E-MI-55817 |
MNDR | hsa-miR-503-5p | Bladder urothelial carcinoma | MNDR-E-MI-55818 |
MNDR | hsa-miR-503-5p | Pancreatic adenocarcinoma | MNDR-E-MI-55819 |
MNDR | hsa-miR-503-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-55820 |
MNDR | hsa-miR-503-5p | Clear cell renal cell carcinoma | MNDR-E-MI-55821 |
MNDR | hsa-miR-503-5p | Esophageal cancer | MNDR-E-MI-55822 |
MNDR | hsa-miR-503-5p | Synovial sarcoma | MNDR-E-MI-55823 |
MNDR | hsa-miR-503-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-55824 |
MNDR | hsa-miR-503-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-55825 |
MNDR | hsa-miR-503-5p | Breast invasive carcinoma | MNDR-E-MI-55826 |
MNDR | hsa-miR-503-5p | Hepatocellular carcinoma | MNDR-E-MI-55827 |
MNDR | hsa-miR-503-5p | Retinoblastoma | MNDR-E-MI-55828 |
MNDR | hsa-miR-503-5p | Tonsil cancer | MNDR-E-MI-55829 |
MNDR | hsa-miR-503-5p | Neuromyelitis optica | MNDR-E-MI-55830 |
MNDR | hsa-miR-503-5p | Colorectal cancer | MNDR-E-MI-55831 |
MNDR | hsa-miR-503-5p | Nasopharynx carcinoma | MNDR-E-MI-55832 |
MNDR | hsa-miR-503-5p | Nasopharyngeal cancer | MNDR-E-MI-55833 |
MNDR | hsa-miR-503-5p | Chronic pain | MNDR-E-MI-55834 |
MNDR | hsa-miR-503-5p | Stroke lacunar | MNDR-E-MI-55835 |
MNDR | hsa-miR-503-5p | Duke A | MNDR-E-MI-55836 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AGO1 | Homo sapiens | RR00055430 |
TOP